1 Genomic Test Can Diagnose Nearly Any Infection
A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
University of California San Francisco
Give to UCSFA decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
With RSV season approachgin, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors.
Several cases of the bird flu in humans have been reported in California's Central Valley in 2024. This Q&A explores how the virus spreads, how to prevent infection and whether this is something to be we need to actively protect against.
A new study on doxy-PEP sheds light on whether people who are regular users become resistance to this treatment, which often serves as a “morning after” pill to prevent sexually transmitted diseases.
A talk on how breathing affects our mood took first place at this year's Postdoc Slam event, which is held in celebration of National Postdoc Appreciation Week.
An extra-long summer surge driven by new variants has prompted the early release of updated COVID-19 vaccines. A UCSF expert tells us what new vaccines could mean for the summer surge, who should get vaccinated, and when/where to get your vaccines.
Seth Blumberg, MD, PhD, explains the viral disease mpox, and what the recent emergency declaration from the World Health Organization means for us.
A study determines that a life-saving, inexpensive antibiotic, azithromycin, must be given to all children up to 5 years old in Sub-Sharan Africa to realize its full potential.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
Scientists at UCSF discovered how kids were developing multisystem inflammatory syndrome in children (MIS-C), a mysterious, life-threatening condition following a COVID infection.
Researchers Micheal Peluso and Valerie Flaherman answer questions about what we know about one of COVID’s most enduring mysteries, including how to potentially reduce your risk and who is most likely to develop long COVID.
Adverse symptoms from the COVID-19 vaccine such as chills and headaches are linked to a robust antibody response, indicating increased efficacy compared with recipients who did not experience side effects.
A clinical trial supported by the NIH has found that intravenous acetaminophen reduced sepsis patients’ risk of having organ injury or developing acute respiratory distress syndrome (ARDS), a serious condition that allows fluid to leak into the lungs.
Researchers have found links between lung microbial communities and mortality risk in pediatric bone marrow transplant patients. Metagenomic sequencing revealed distinct patient clusters and unexpected pathogens, highlighting the need for precise diagnostics and therapeutics. Antibiotic treatment was associated with bacterial depletion and enriched viral and fungal populations.
A study reveals the life-altering impact of COVID-19 on individuals who developed severe illness, the majority of whom had to be placed on mechanical ventilators. Two-thirds still had physical, psychiatric, and cognitive problems for up to a year later.
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.